Group 1 - The core product, Norwegian pure krill oil, has become a leading brand in China, achieving the title of "China's e-commerce krill oil sales champion" for four consecutive years and serving over 10 million families [1] - NYO3 aims to become "the leading anti-aging brand in Northern Europe" by 2024 and to achieve "global krill oil sales leader" certification by 2025, showcasing a significant transformation from an exhibition sample to an industry benchmark [1] - The company has established a comprehensive distribution network covering major online platforms like Tmall and JD, as well as over 200 offline stores in Hong Kong and Macau [1] Group 2 - NYO3 launched the "Anti-Aging Trio" products, including Ageless deep-sea collagen peptides, beauty pills, and noble nest pills, which utilize a pioneering phospholipid delivery technology with over 98% absorption rate [2] - The Ageless deep-sea collagen peptides contain 6100mg of collagen tripeptides for rapid absorption, while the beauty pills have been validated for "7-day tightening" and the noble nest pills have reached the top position in Tmall's category [2] - The growth trajectory of NYO3 illustrates the transformative power of the China International Import Expo, demonstrating how products can evolve from exhibits to commercial successes, providing a model for global brands to penetrate the Chinese market [2]

Core Viewpoint - VIKPRO showcased its new product, the "Nurturing Ovarian Pill," at the Vitafoods Europe 2025 event, highlighting its commitment to women's health and innovative nutritional solutions [1][7]. Group 1: Product Launch and Market Position - VIKPRO received dual first-place market position certifications for Coenzyme Q10 and Quercetin from Euromonitor International, affirming its status as a leader in sales and product quality [3]. - The "Nurturing Ovarian Pill" is designed to enhance ovarian vitality through a three-dimensional targeting strategy, addressing cellular repair, energy revitalization, and hormonal balance for women over 35 [7][9]. Group 2: Scientific Collaboration and Innovation - VIKPRO has established a strategic partnership with Düsseldorf Medical University and appointed Prof. Dr. Nicole Teusch as the chief scientific advisor to enhance its research capabilities and product development [5]. - The company emphasizes a cell-level health approach, integrating advanced German technology to innovate and upgrade its product offerings [5][12]. Group 3: Consumer Engagement and Market Strategy - The new product has been well-received in the Chinese market during the Tmall 618 pre-sale, indicating strong consumer interest and positive feedback [10]. - VIKPRO aims to continue expanding in the European health market, focusing on consumer needs and collaborating with global partners to deliver high-quality health products [12].